Sweden · Delayed Price · Currency is SEK NextCell Pharma AB Statistics
Total Valuation
STO:NXTCL has a market cap or net worth of SEK 116.96 million. The enterprise value is 84.63 million.
| Market Cap | 116.96M |
| Enterprise Value | 84.63M |
Important Dates
The last earnings date was Thursday, May 28, 2026.
| Earnings Date | May 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:NXTCL has 111.39 million shares outstanding.
| Current Share Class | 111.39M |
| Shares Outstanding | 111.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.01% |
| Owned by Institutions (%) | 30.03% |
| Float | 85.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.65 |
| PB Ratio | 2.13 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.90
| Current Ratio | 4.90 |
| Quick Ratio | 4.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11,883.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -70.15% |
| Weighted Average Cost of Capital (WACC) | 8.03% |
| Revenue Per Employee | 385,136 |
| Profits Per Employee | -1.73M |
| Employee Count | 24 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.57% in the last 52 weeks. The beta is 0.69, so STO:NXTCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -0.57% |
| 50-Day Moving Average | 1.20 |
| 200-Day Moving Average | 1.09 |
| Relative Strength Index (RSI) | 39.76 |
| Average Volume (20 Days) | 261,936 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:NXTCL had revenue of SEK 9.24 million and -41.58 million in losses.
| Revenue | 9.24M |
| Gross Profit | 1.57M |
| Operating Income | -42.16M |
| Pretax Income | -41.58M |
| Net Income | -41.58M |
| EBITDA | -39.67M |
| EBIT | -42.16M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 32.33 million in cash and n/a in debt, with a net cash position of 32.33 million or 0.29 per share.
| Cash & Cash Equivalents | 32.33M |
| Total Debt | n/a |
| Net Cash | 32.33M |
| Net Cash Per Share | 0.29 |
| Equity (Book Value) | 54.99M |
| Book Value Per Share | n/a |
| Working Capital | 37.89M |
Cash Flow
In the last 12 months, operating cash flow was -40.73 million and capital expenditures -3.58 million, giving a free cash flow of -44.31 million.
| Operating Cash Flow | -40.73M |
| Capital Expenditures | -3.58M |
| Depreciation & Amortization | 2.49M |
| Net Borrowing | 836,724 |
| Free Cash Flow | -44.31M |
| FCF Per Share | -0.40 |
Margins
| Gross Margin | 16.97% |
| Operating Margin | -456.13% |
| Pretax Margin | -449.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:NXTCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -35.55% |
| FCF Yield | -37.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |